Articles with "atazanavir" as a keyword



Photo by averey from unsplash

Long‐term oral atazanavir attenuates myocardial infarction‐induced cardiac fibrosis

Sign Up to like & get
recommendations!
Published in 2018 at "European Journal of Pharmacology"

DOI: 10.1016/j.ejphar.2018.03.041

Abstract: ABSTRACT Atazanavir is an antiretroviral medication used to treat and prevent HIV/AIDS, but its effects on cardiac fibrosis are unknown. The aim of this study was to determine the effects of atazanavir on myocardial infarction… read more here.

Keywords: induced cardiac; myocardial infarction; cardiac fibrosis; infarction induced ... See more keywords
Photo from wikipedia

Effect of body weight and composition on efavirenz, atazanavir or darunavir concentration.

Sign Up to like & get
recommendations!
Published in 2018 at "Therapie"

DOI: 10.1016/j.therap.2017.08.007

Abstract: BACKGROUND To compare the steady state plasma concentrations (Css) of three antiretroviral drugs in both normal and overweight patients, and to determine the relationship between Css and fat mass (FM) or lean body mass. METHODS… read more here.

Keywords: darunavir; effect; composition; concentration ... See more keywords
Photo from wikipedia

Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Antimicrobial Chemotherapy"

DOI: 10.1093/jac/dkx274

Abstract: Background Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester. Objectives To evaluate plasma and intracellular atazanavir and… read more here.

Keywords: pregnancy; intracellular concentrations; ritonavir; hiv infected ... See more keywords
Photo by nampoh from unsplash

Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Pediatrics"

DOI: 10.3389/fped.2022.913105

Abstract: Background Atazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review to assess safety and effectiveness of atazanavir use in children and… read more here.

Keywords: safety; effectiveness; children adolescents; atazanavir ... See more keywords